These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 1853948
21. The effects of fenfluramine on sleep and prolactin in depressed inpatients: a comparison of potential indices of brain serotonergic responsivity. Myers JE, Buysse DJ, Thase ME, Perel J, Miewald JM, Cooper TB, Kupfer DJ, Mann JJ. Biol Psychiatry; 1993 Dec 01; 34(11):753-8. PubMed ID: 8292678 [Abstract] [Full Text] [Related]
22. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects. Ramasubbu R, Flint A, Brown G, Awad G, Kennedy S. Stroke; 1998 Jul 01; 29(7):1293-8. PubMed ID: 9660375 [Abstract] [Full Text] [Related]
23. Cholesterol and serotonin indices in depressed and suicidal patients. Sarchiapone M, Camardese G, Roy A, Della Casa S, Satta MA, Gonzalez B, Berman J, De Risio S. J Affect Disord; 2001 Feb 01; 62(3):217-9. PubMed ID: 11223109 [Abstract] [Full Text] [Related]
24. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Duval F, Mokrani MC, Correa H, Bailey P, Valdebenito M, Monreal J, Crocq MA, Macher JP. Psychoneuroendocrinology; 2001 Jul 01; 26(5):521-37. PubMed ID: 11337135 [Abstract] [Full Text] [Related]
25. Future suicide attempt and responses to serotonergic challenge. Keilp JG, Oquendo MA, Stanley BH, Burke AK, Cooper TB, Malone KM, Mann JJ. Neuropsychopharmacology; 2010 Apr 01; 35(5):1063-72. PubMed ID: 18354392 [Abstract] [Full Text] [Related]
26. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects. Gorard DA, Taylor TM, Medbak SH, Perry LA, Libby GW, Farthing MJ. Int Clin Psychopharmacol; 1993 Apr 01; 8(2):123-8. PubMed ID: 8393895 [Abstract] [Full Text] [Related]
27. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression. Thakore JH, Dinan TG. Biol Psychiatry; 1995 Mar 15; 37(6):364-8. PubMed ID: 7772644 [Abstract] [Full Text] [Related]
28. Blunted serotonergic responsivity in depressed inpatients. Mann JJ, McBride PA, Malone KM, DeMeo M, Keilp J. Neuropsychopharmacology; 1995 Aug 15; 13(1):53-64. PubMed ID: 8526971 [Abstract] [Full Text] [Related]
29. Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review. Newman ME, Shapira B, Lerer B. Int J Neuropsychopharmacol; 1998 Jul 15; 1(1):49-69. PubMed ID: 11281946 [Abstract] [Full Text] [Related]
30. Abnormal behavioral responses to fenfluramine in patients with affective and personality disorders. Correlation with increased serotonergic responsivity. Myers JE, Mieczkowski T, Perel J, Abbondanza D, Cooper TB, Mann JJ. Biol Psychiatry; 1994 Jan 15; 35(2):112-20. PubMed ID: 8167207 [Abstract] [Full Text] [Related]
31. Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients. Weizman A, Mark M, Gil-Ad I, Tyano S, Laron Z. Clin Neuropharmacol; 1988 Jun 15; 11(3):250-6. PubMed ID: 2969772 [Abstract] [Full Text] [Related]
32. Thyroid axis activity and serotonin function in major depressive episode. Duval F, Mokrani MC, Bailey P, Correa H, Diep TS, Crocq MA, Macher JP. Psychoneuroendocrinology; 1999 Oct 15; 24(7):695-712. PubMed ID: 10451906 [Abstract] [Full Text] [Related]
33. Serotonin function in detoxified heroin abusers: prolactin and cortisol responses to fenfluramine challenge. Gerra G, Fertonani G, Tagliavini P, Zaimovic A, Delsignore R, Maestri D, Avanzini P, Caccavari R, Brambilla F. Psychiatry Res; 1995 Sep 29; 58(2):153-60. PubMed ID: 8570767 [Abstract] [Full Text] [Related]
34. Prolactin and cortisol responses to fenfluramine challenge in mania. Yatham LN. Biol Psychiatry; 1996 Feb 15; 39(4):285-8. PubMed ID: 8645775 [Abstract] [Full Text] [Related]
35. Neuroendocrine assessment of serotonin (5-HT) function in chronic fatigue syndrome. Yatham LN, Morehouse RL, Chisholm BT, Haase DA, MacDonald DD, Marrie TJ. Can J Psychiatry; 1995 Mar 15; 40(2):93-6. PubMed ID: 7788624 [Abstract] [Full Text] [Related]
36. 5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis. Mannel M, Müller-Oerlinghausen B, Czernik A, Sauer H. J Affect Disord; 1997 Nov 15; 46(2):101-13. PubMed ID: 9479614 [Abstract] [Full Text] [Related]
37. Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressive treatment. Kasper S, Vieira A, Schmidt R, Richter P. Pharmacopsychiatry; 1990 Mar 15; 23(2):76-84. PubMed ID: 2339181 [Abstract] [Full Text] [Related]
38. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls. Lucey JV, O'Keane V, Butcher G, Clare AW, Dinan TG. Br J Psychiatry; 1992 Oct 15; 161():517-21. PubMed ID: 1393339 [Abstract] [Full Text] [Related]
39. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects. Cleare AJ, Bond AJ. Psychiatry Res; 1997 Mar 24; 69(2-3):89-95. PubMed ID: 9109176 [Abstract] [Full Text] [Related]
40. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. Anand A, Charney DS, Delgado PL, McDougle CJ, Heninger GR, Price LH. Am J Psychiatry; 1994 Nov 24; 151(11):1626-30. PubMed ID: 7943451 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]